Lawrence Korngut
Investigator
Neuromuscular Neurologist, Professor, Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary
NMD4C Involvement: Pillar 2: Clinical Research, Theme 5: Open Science
Email LawrenceBiography
Dr. Lawrence Korngut is a neurologist, clinical neurophysiologist and former Director of the Calgary Neuromuscular Program and the Calgary ALS and Motor Neuron Disease Clinic. His research includes phase II and III clinical trials of new therapies for neuromuscular conditions. He is the National Principal Investigator of the Canadian Neuromuscular Disease Registry that now includes 48 participating clinics and over the past ten years has recruited over 5500 patients.
Dr. Korngut completed his undergraduate degree in Life Sciences at Queen’s University (Kingston, Canada), medical school and neurology residency at Western University (London, Canada), neuromuscular clinical and research fellowship and Masters of Science in Clinical Epidemiology at the University of Calgary, Alberta, Canada. He serves as the Director of Innovation and Commercialization at the Hotchkiss Brain Institute.
Within NMD4C Dr. Korngut will bring in his experience of Canadian networking in CAN-NMD and participates in the network’s work in trial capacity building.
Recent Publications
Baumeister, TR, Westeneng, HJ, van den Berg, L, Canadian ALS Neuroimaging Consortium (CALSNIC), Kalra, S, Iturria-Medina, Y et al.. Multimodal Neuroimaging-Guided Stratification in Amyotrophic Lateral Sclerosis Reveals Three Disease Subtypes: A Multi-Cohort Analysis. Hum Brain Mapp. 2025.46 (14)e70341 PMID:40990258
Schellenberg, KL, Caspar-Bell, G, Ellis, C, Johnston, W, King, A, King, M et al.. Best practice recommendations for the clinical care of spinal bulbar muscular atrophy. CMAJ. 2025.197 (31)E987-E999 PMID:40983380
Parnianpour, P, Harrison, M, Benatar, M, Briemberg, H, Dionne, A, Dupré, N et al.. Progressive and short-interval changes observed in the corticospinal tract and corpus callosum of ALS patients: A texture analysis study. AJNR Am J Neuroradiol. 2025. PMID:40968018
Grant, A, Smith, IC, Lessard, LER, Osman, H, Lochmuller, H, McMillan, HJ et al.. Financial Toxicity and Its Determinants in Individuals Living With Inherited and Acquired Neuromuscular Disorders: The BIND Study. Neurology. 2025.105 (5)e213982 PMID:40834345
Smith, IC, Abusetah, Y, Osman, H, Garg, A, Grant, A, Lochmuller, H et al.. Assessing the socio-economic burden of inherited and inflammatory neuromuscular diseases (BIND study): a study protocol. Orphanet J Rare Dis. 2025.20 (1)404 PMID:40770363
See more on PubMed